natgillin/translations-raw huggingface dataset:
The dose and duration of the treatment depend on the clinical status of the patient, the type and severity of the bleeding, and both VWF:RCo and FVIII:C levels.
Odmerek in trajanje zdravljenja sta odvisna od kliničnega stanja bolnika, vrste in resnosti krvavitve ter ravni obeh faktorjev VWF:RCo in FVIII:C.
The dose and duration of the treatment depend on the severity of the factor X deficiency (i.e. the patient’s baseline factor X level), on the location and extent of the bleeding and on the patient’s clinical condition.
Odmerjanje in trajanje zdravljenja sta odvisna od resnosti pomanjkanja faktorja X (npr. od bolnikove izhodiščne ravni faktorja X), od mesta in obsega krvavitve in od kliničnega stanja bolnika.
The dose and duration of treatment also depend on the severity of the disease, the extent and location of the bleeding, the clinical condition of the patient and the patient’s age and bodyweight.
Odmerek in trajanje zdravljenja sta prav tako odvisna od resnosti bolezni, obsega in mesta krvavitve, kliničnega stanja bolnika ter njegove starosti in telesne mase.
The dose and duration of treatment depend on the disease being treated and the response of the patient, with doses ranging from 2 to 20 million IU per square metre of body surface area (calculated using the patient’s height and weight).
Odmerek in trajanje zdravljenja sta odvisna od zdravljene bolezni in odziva bolnika, pri čemer se odmerki gibljejo v razponu od 2 do 20 milijonov mednarodnih enot na kvadratni meter telesne površine (ki se izračuna na podlagi bolnikove telesne višine in mase).
The dose and duration of treatment depend on the nature and severity of the infection, the weight and species of the animal being treated, and the animal’s response to treatment.
Odmerek zdravila in trajanje zdravljenja sta odvisna od narave in resnosti okužbe, telesne mase in vrste živali, ki jo zdravimo, ter od tega, kako se žival na zdravljenje odziva.
The dose and duration of treatment depend on the species of the animal being treated and its body weight, the nature and severity of the infection, and the animal’s response to the treatment.
Odmerek in trajanje zdravljenja sta odvisna od živalske vrste, njene telesne mase, narave in resnosti okužbe ter odziva živali na zdravljenje.
The dose and duration of treatment depend on whether Voncento is used to treat or prevent bleeding and whether it is used in patients with haemophilia A or von Willebrand disease.
Odmerek in trajanje zdravljenja sta odvisna od tega, ali se zdravilo Voncento uporablja za zdravljenje ali preprečevanje krvavenja in ali se uporablja pri bolnikih s hemofilijo A ali von Willebrandovo boleznijo.
The dose and duration of treatment in adults and children are the same.
Odmerjanje in trajanje zdravljenja pri odraslih in otrocih sta enaka.
The dose and frequency depend on whether Advate is used to treat or prevent bleeding.
Odmerek in pogostnost sta odvisna od tega ali se zdravilo uporablja za zdravljenje ali preprečevanje krvavitev.
The dose and frequency of administration of Fertavid depend on its use (see above) and the patient’s response to treatment.
Odmerjanje in pogostnost dajanja zdravila Fertavid sta odvisna od načina uporabe (glejte zgoraj) in bolnikovega odziva na zdravljenje.
The dose and frequency of administration of Puregon depend on its use (see above) and the patient’s response to treatment.
Odmerjanje in pogostnost dajanja zdravila Puregon sta odvisna od načina njegove uporabe (glejte zgoraj) in od bolnikovega odziva na zdravljenje.
The dose and frequency of application depends on why Advocate is being used and whether it is used in cats, ferrets or dogs; the package leaflet includes detailed information on dosage and duration of treatment.
Odmerek in pogostost nanosa sta odvisna od razloga za uporabo zdravila Advocate in od tega, ali se uporablja pri mačkah, belih dihurjih ali psih.
The dose and frequency of infusion depend on the patient’s age and body surface area.
Odmerek in pogostost infuzije sta odvisna od bolnikove starosti in telesne površine.
The dose and frequency of infusions depend on the disease being treated and may need to be adjusted depending on the patient’s response.
Odmerek in pogostost infuzij sta odvisna od zdravljene bolezni in ju bo morda treba prilagoditi glede na bolnikov odziv.
The dose and frequency of injection depend on whether Helixate NexGen is used to treat or prevent bleeding, or to reduce bleeding during surgery.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Helixate NexGen uporablja za zdravljenje ali preprečevanje krvavitev ali za zmanjšanje krvavitev med operacijo.
The dose and frequency of injection depend on whether Kogenate Bayer is used to treat or prevent bleeding, or to reduce bleeding during surgery.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Kogenate Bayer uporablja za zdravljenje ali preprečevanje krvavitev ali za zmanjšanje krvavitev med operacijo.
The dose and frequency of injection depends on the condition to be treated and, when used for a child, the dose is calculated according to the child’s weight and height.
Odmerek in pogostnost injiciranja sta odvisna od bolezni, ki se jo zdravi, pri otrocih pa se odmerek izračuna na podlagi telesne mase in višine otroka.
The dose and frequency of the injections depend on the severity of the patient’s factor X deficiency, the extent and location of the bleeding and the patient’s condition and bodyweight.
Odmerek in pogostnost injiciranja sta odvisna od resnosti bolnikovega pomanjkanja faktorja X, obsega in mesta krvavitve ter bolnikovega stanja in telesne mase.
The dose and frequency of the injections depend on whether Elocta is used to treat or prevent bleeding, the severity of the patient’s factor VIII deficiency, the extent and location of the bleeding and the patient’s condition and bodyweight.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Elocta uporablja za zdravljenje ali preprečevanje krvavitve, resnosti bolnikovega pomanjkanja faktorja VIII, obsega in mesta krvavitve ter bolnikovega stanja in telesne mase.
The dose and frequency of the injections depend on whether Iblias is used to treat or prevent bleeding, the severity of the patient’s factor VIII deficiency, the extent and location of the bleeding and the patient’s condition and bodyweight.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Iblias uporablja za zdravljenje ali preprečevanje krvavitve, resnosti bolnikovega pomanjkanja faktorja VIII, obsega in mesta krvavitve ter bolnikovega stanja in telesne mase.
The dose and frequency of the injections depend on whether Kovaltry is used to treat or prevent bleeding, the severity of the patient’s factor VIII deficiency, the extent and location of the bleeding and the patient’s condition and bodyweight.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Kovaltry uporablja za zdravljenje ali preprečevanje krvavitve, od resnosti bolnikovega pomanjkanja faktorja VIII, obsega in mesta krvavitve ter bolnikovega stanja in telesne mase.
The dose and frequency of treatment depend on the patient’s bodyweight and whether Alprolix is used to treat or prevent bleeding, as well as the severity of the patient’s factor IX deficiency, the extent and location of the bleeding and the patient’s age and health.
Odmerek in pogostnost injiciranja sta odvisna od bolnikove telesne mase in tega, ali se zdravilo Alprolix uporablja za zdravljenje ali preprečevanje krvavitve, ter resnosti bolnikovega pomanjkanja faktorja IX, obsega in mesta krvavitve ter bolnikove starosti in stanja.
The dose and frequency of treatment depend on the patient’s bodyweight and whether Rixubis is used to treat or prevent bleeding, as well as the seriousness of the haemophilia, the extent and location of the bleeding and the patient’s age and health.
Odmerek in pogostost uporabe zdravila sta odvisna od telesne mase bolnika, tega, ali se zdravilo Rixubis uporablja za zdravljenje ali preprečevanje krvavitev, od resnosti hemofilije, obsega in mesta krvavitve ter bolnikove starosti in zdravja.
The dose and frequency of treatment depend on whether it is used to treat or prevent bleeding, as well as on the seriousness of the haemophilia, the extent and location of the bleeding and the patient’s condition and bodyweight.
Odmerek in pogostnost dajanja zdravila sta odvisna od tega, ali se uporablja za zdravljenje ali preprečevanje krvavitev, ter tudi od stopnje resnosti hemofilije, obsega in mesta krvavitve ter kliničnega stanja in telesne mase bolnika.
The dose and frequency of treatment depend on whether it is used to treat or prevent bleeding, as well as the seriousness of the haemophilia, the extent and location of the bleeding and the patient’s condition.
Odmerek in pogostnost dajanja zdravila sta odvisna od tega, ali se uporablja za zdravljenje ali preprečevanje krvavitev, ter tudi od stopnje resnosti hemofilije, obsega in mesta krvavitve ter kliničnega stanja bolnika.
The dose and frequency to be given depends on whether it is used alone or in combination with ipilimumab.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo uporablja samostojno ali v kombinaciji z ipilimumabom.
The dose and how often the infusions are given need to be adjusted according to each individual patient’s symptoms and response to treatment.
Odmerek in pogostost dajanja infuzij je treba prilagoditi glede na posameznikove simptome in odziv na zdravljenje.
The dose and length of treatment depends on the condition, the animal for which it is being used and its bodyweight.
Odmerek in trajanje zdravljenja sta odvisna od stanja ter živali, za katero se zdravilo uporablja, in njene telesne mase.
The dose and number of injections depend on the patient’s response.
Odmerek in število injekcij sta odvisna od odziva bolnika.
The dose and the duration of substitution therapy depend on the severity of the factor IX deficiency.
Odmerjanje in trajanje nadomestnega zdravljenja sta odvisna od hudosti pomanjkanja faktorja IX.
The dose and the frequency of dosing depend on whether or not Mircera is replacing another medicine used to stimulate the production of red blood cells.
Odmerek in pogostost odmerjanja sta odvisna od tega, ali zdravilo Mircera nadomešča drugo zdravilo, ki se uporablja za stimulacijo tvorbe rdečih krvničk, ali ne.
The dose and the frequency of injection depend on whether BeneFIX is used to treat or prevent bleeding, or to reduce bleeding during surgery, and on the patient’s condition.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo BeneFIX uporablja za zdravljenje ali preprečevanje krvavitev ali za zmanjšanje krvavitev med kirurškim posegom, in od bolnikovega stanja.
The dose and the frequency of the injections depend on the patient’s bodyweight and whether Idelvion is used to treat or prevent bleeding, as well as the severity of the patient’s factor IX deficiency, the extent and location of the bleeding and the patient’s age and health.
Odmerek in pogostnost injiciranja sta odvisna od tega, ali se zdravilo Idelvion uporablja za zdravljenje ali preprečevanje krvavitve, resnosti bolnikovega pomanjkanja faktorja IX, obsega in mesta krvavitve ter bolnikove starosti in telesne mase.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temomedac is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja, od tega, ali je bil bolnik že zdravljen, od tega, ali se zdravilo Temomedac uporablja samostojno ali skupaj z drugimi zdravljenji, in od tega, kako se bolnik odziva na zdravljenje.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Accord is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja ter od tega, ali je bil bolnik že zdravljen, ali se zdravilo Temozolomide Accord uporablja samostojno ali skupaj z drugimi zdravljenji in kako se bolnik odziva na zdravljenje.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Hexal is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja ter od tega, ali je bil bolnik že zdravljen, ali se zdravilo Temozolomide Hexal uporablja samostojno ali skupaj z drugimi zdravljenji in kako se bolnik odziva na zdravljenje.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Sandoz is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja ter od tega, ali je bil bolnik že zdravljen, ali se zdravilo Temozolomide Sandoz uporablja samostojno ali skupaj z drugimi zdravljenji in kako se bolnik odziva na zdravljenje.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Sun is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja ter od tega, ali je bil bolnik že zdravljen, ali se zdravilo Temozolomide Sun uporablja samostojno ali skupaj z drugimi zdravljenji in kako se bolnik odziva na zdravljenje.
The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Teva is being used alone or with other treatments, and how the patient responds to treatment.
Odmerek in število odmerkov sta odvisna od vrste zdravljenega tumorja ter od tega, ali je bil bolnik že zdravljen, ali se zdravilo Temozolomide Teva uporablja samostojno oziroma skupaj z drugimi zdravljenji in kako se bolnik odziva na zdravljenje.
The dose and the number of REYATAZ oral powder sachets needed is determined based on weight (see section 4.2.).
Odmerek in število potrebnih vrečic zdravila REYATAZ peroralni prašek se določi na osnovi telesne mase (glejte poglavje 4.2).
The dose and treatment frequency is given below.
Odmerek in pogostnost uporabe zdravila prikazuje spodnja tabela.
The dose and treatment frequency is given below.
Odmerek in pogostnost uporabe zdravila sta navedena v nadaljevanju.
The dose at which no adverse reproductive effects were observed in males (30 mg/kg/day) and females (3 mg/kg/day) resulted in exposures equal to 0.5 and 0.2-times, respectively, the human exposure resulting from the clinical dose of 500 mg (based on unbound AUC in the respective species).
Odmerki, pri katerih niso opazili neželenih učinkov na razmnoževanje, so pri samcih (30 mg/kg/dan) znašali 0,5-kratnik in pri samicah (3 mg/kg/dan) 0,2-kratnik izpostavljenosti pri človeku, ki je posledica kliničnega odmerka 500 mg (na podlagi nevezane AUC pri posamezni vrsti).
The dose can be adjusted according to each patient’s symptoms and response to treatment.
Odmerek se lahko prilagodi glede na simptome vsakega posameznega bolnika in njegov odziv na zdravljenje.
The dose can be adjusted according to the patient’s response to the treatment, but should be kept within the range of 25 to 75 mg.
Odmerek se lahko prilagodi bolnikovemu odzivu na zdravljenje, vendar pa ne sme biti nižji od 25 mg ali višji od 75 mg.
The dose can be adjusted according to the patient’s response.
Lahko se ga prilagodi glede na bolnikov odziv.
The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
Odmerek je mogoče popraviti z obračanjem gumba za odmerjanje v obe smeri, dokler se pravi odmerek ne poravna s kazalnikom odmerka.
The dose can be corrected by turning the Dose Knob in either direction until the correct dose lines up with the Dose Indicator.
Odmerek je mogoče popraviti z obračanjem gumba za odmerjanje v obe smeri, dokler se pravi odmerek ne poravna s kazalnikom odmerkov.
The dose can be corrected either up or down by turning the dose selector in either direction until the correct dose lines up with the pointer.
Odmerek lahko popravite navzgor ali navzdol tako, da izbirnik odmerka zavrtite v eno ali drugo smer, dokler pravilni odmerek ni uravnan s kazalnikom.
The dose can be decreased to 25 mg if the patient shows signs of damage to the nerves (such as headache, abnormal vision, muscle weakness or pain).
Odmerek se nato lahko zmanjša na 25 mg, če bolnik kaže znake poškodbe živcev (kot so glavobol, neobičajen vid ali šibkost oziroma bolečine v mišicah).
The dose can be further increased at two-week intervals according to the patient’s response, to a maximum dose of 1,500 mg twice a day.
Odmerek se lahko glede na bolnikov odziv še naprej povečuje v dvotedenskih presledkih do največjega odmerka 1 500 mg dvakrat na dan.
The dose can be further increased at two-week intervals according to the patient’s response, to a maximum dose of 1,500 mg twice a day.
Odmerki se lahko glede na bolnikov odziv še naprej povečujejo v dvotedenskih presledkih do največjega odmerka 1 500 mg dvakrat dnevno.
The dose can be further increased at two-week intervals according to the patient’s response, to a maximum dose of 1,500 mg twice a day.
Odmerki se lahko glede na bolnikov odziv še naprej povečujejo v dvotedenskih razmakih do največjega odmerka 1 500 mg dvakrat dnevno.
The dose can be further increased at two-week intervals according to the patient’s response, to a maximum dose of 1500 mg twice a day.
Odmerki se lahko glede na bolnikov odziv še naprej povečujejo v dvotedenskih razmakih do največjega odmerka 1 500 mg dvakrat na dan.
The dose can be further increased by 250 mg twice daily every two weeks depending upon the clinical response.
Odmerek se lahko poveča za 250 mg dvakrat na dan vsaka dva tedna glede na klinični odziv.
The dose can be increased or decreased by 1 to 2 g (1 to 2 tablets) per day at 2- to 4-week intervals as needed to maintain serum phosphorus at recommended target levels up to a maximum of 12 g (12 tablets) per day.
Odmerek je mogoče povečati ali zmanjšati za 1 do 2 g (1 do 2 tableti) na dan v 2- do 4-tedenskih presledkih, kot je potrebno za vzdrževanje priporočenih ciljnih ravni fosforja v serumu, do največ 12 g (12 tablet) na dan.
The dose can be increased or decreased on the basis of the patient’s response to the medicine.
Odmerek se lahko v skladu z bolnikovim odzivom na zdravilo poveča ali zmanjša.
The dose can be increased to 25 mg if 12.5 mg is well tolerated by the patient (see section 4.5).
Odmerek je mogoče povečati na 25 mg, če bolnik dobro prenaša odmerek 12,5 mg (glejte poglavje 4.5).
The dose can be individually established and adapted from 500 IU up to 1,000 IU (in exceptional cases up to 1,500 IU) subcutaneous injections on a weekly or fortnightly basis, according to the serum anti- HBs concentrations and at the discretion of the physician in charge.
Odmerek se lahko določi za vsakega bolnika posebej in prilagodi s 500 i.e. na največ 1.000 i.e. (v izjemnih primerih do 1.500 i.e.) subkutanih injekcij na teden ali vsaka dva tedna, glede na serumske koncentracije protiteles anti-HBs in po presoji lečečega zdravnika.
The dose can be set in steps of 1 unit, from a minimum of 1 unit to a maximum of 80 units.
Odmerek lahko nastavite v korakih po 1 enoto, od najmanj 1 enote do največ 80 enot.
The dose can be set in steps of 2 units, from a minimum of 2 units to a maximum of 40 units.
Odmerek je mogoče nastaviti v korakih po 2 enoti, od najmanj 2 enot do največ 40 enot.
The dose can then be adjusted according to the patient’s needs up to a maximum of 100 mg twice a day.
Odmerek se lahko prilagodi glede na bolnikove potrebe do največ 100 mg dvakrat na dan.
The dose combinations are : 45 mg + 15 mg
Kombinacije odmerkov so: 45 mg + 15 mg
The dose could be reduced by decrements of 0.3 mg twice daily at any time during the study for reasons of intolerability.
Odmerek so kadarkoli v poteku študije lahko znižali, če ga bolnik ni prenašal, in sicer v korakih po 0,3 mg dvakrat na dan.
The dose counter
Števec odmerkov
The dose counter and the dose pointer show how many dose steps of Xultophy you select.
Števec odmerka in kazalnik odmerka kažeta, koliko odmernih korakov zdravila Xultophy ste izbrali.
The dose counter counts down by 1 to confirm.
Števec odmerkov odšteva po ena.
The dose counter enables you, and your doctor, to monitor and adapt your use.
Števec odmerkov vam in tudi zdravniku omogoča spremljanje in prilagajanje vaše uporabe zdravila.
The dose counter of your pen shows the exact number of insulin units.
Števec odmerka na injekcijskem peresniku kaže število enot insulina, ki ste jih izbrali; prikazani odmerek upoštevajte in ga ne preračunavajte.
The dose counter on the pen shows the number of dose steps.
Števec odmerka na injekcijskem peresniku kaže število odmernih korakov.
The dose counter shows the dose dialled in units.
Števec odmerka na injekcijskem peresniku kaže število enot insulina, ki ste jih izbrali;
The dose delivered by the I-Neb AAD system is controlled by the medication chamber in combination with a control disc.
Prostor za zdravilo v kombinaciji z nadzornim diskom nadzira odmerek, ki ga dovede nebulator I-Neb AAD.
The dose depends on the age and condition of the patient, and the response to treatment, but it should not exceed 800 mg a day.
Odmerek je odvisen od starosti bolnika, njegovega bolezenskega stanja in odziva na zdravljenje, vendar ne sme presegati 800 mg na dan.
The dose depends on the age and condition of the patient, and the response to treatment, but it should not exceed 800 mg a day.
Odmerek je odvisen od starosti in stanja bolnika ter odziva na zdravljenje, v nobenem primeru pa ne sme preseči 800 mg na dan.
The dose depends on the body surface area (calculated using the patient’s height and weight).
Odmerek je odvisen od telesne površine (izračunane na podlagi telesne višine in mase bolnika).
The dose depends on the body surface area in dogs (calculated using bodyweight) and
Odmerek je pri psih odvisen od telesne površine (izračuna se s pomočjo telesne mase), pri mačkah pa od telesne mase.
The dose depends on the body weight of the dog being treated.
Odmerek je odvisen od telesne mase psa, ki se zdravi.
The dose depends on the child’s body weight.
Odmerek je odvisen od telesne mase otroka.
The dose depends on the child’s body weight.
Uporabljeni odmerek je odvisen od otrokove telesne mase.
The dose depends on the condition it is being used to treat and how
Odmerek je odvisen od pogojev, pod katerimi se uporablja za zdravljenje, od
The dose depends on the disease being treated, the age and condition of the patient, and the response to treatment, but it should not exceed 800 mg a day.
Odmerek je odvisen od zdravljene bolezni, starosti in stanja bolnika ter odziva na zdravljenje, vendar pa ne sme preseči 800 mg na dan.
The dose depends on the disease being treated, the age and condition of the patient, and the response to treatment, but it should not exceed 800 mg a day.
Odmerjanje je odvisno od zdravljene bolezni, starosti in stanja bolnika ter odziva na zdravljenje, vendar ne sme preseči 800 mg na dan.
The dose depends on the disease being treated, the age and condition of the patient, and the response to treatment, but it should not exceed 800 mg a day.
Odmerjanje je odvisno od zdravljene bolezni, starosti in stanja bolnika ter odziva na zdravljenje, vendar pa ne sme preseči 800 mg na dan.
The dose depends on the likelihood that you form a blood clot.
Odmerek je odvisen od vašega tveganja za nastanek strdka.
The dose depends on the patient’s body weight and should be reduced in patients who have severe problems with their kidneys.
Odmerek je odvisen od bolnikove telesne mase in ga je treba pri bolnikih s težjo ledvično okvaro ustrezno zmanjšati.
The dose depends on the patient’s body weight.
Odmerek je odvisen od bolnikove telesne mase.
The dose depends on the patient’s weight.
Odmerek je odvisen od bolnikove telesne mase.